182 related articles for article (PubMed ID: 36961909)
1. Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines.
Tawfeeq N; Lazarte JMS; Jin Y; Gregory MD; Lamango NS
Oncotarget; 2023 Mar; 14():243-257. PubMed ID: 36961909
[TBL] [Abstract][Full Text] [Related]
2. Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling.
Lamango NS; Nkembo AT; Ntantie E; Tawfeeq N
Curr Med Chem; 2021; 28(18):3476-3489. PubMed ID: 33176634
[TBL] [Abstract][Full Text] [Related]
3. Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer.
Ntantie E; Fletcher J; Amissah F; Salako OO; Nkembo AT; Poku RA; Ikpatt FO; Lamango NS
Oncotarget; 2017 May; 8(19):31726-31744. PubMed ID: 28423648
[TBL] [Abstract][Full Text] [Related]
4. Activation of MAP Kinase Pathway by Polyisoprenylated Cysteinyl Amide Inhibitors Causes Apoptosis and Disrupts Breast Cancer Cell Invasion.
Lazarte JMS; Lamango NS
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540084
[TBL] [Abstract][Full Text] [Related]
5. Polyisoprenylated Cysteinyl Amide Inhibitors Deplete K-Ras and Induce Caspase-dependent Apoptosis in Lung Cancer Cells.
Nkembo AT; Amissah F; Ntantie E; Poku RA; Salako OO; Ikpatt OF; Lamango NS
Curr Cancer Drug Targets; 2019; 19(10):838-851. PubMed ID: 30914025
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Optimization and MAPK Pathway Activation Anticancer Mechanism of Polyisoprenylated Cysteinyl Amide Inhibitors.
Tawfeeq N; Jin Y; Lamango NS
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830912
[TBL] [Abstract][Full Text] [Related]
7. Polyisoprenylated cysteinyl amide inhibitors induce caspase 3/7- and 8-mediated apoptosis and inhibit migration and invasion of metastatic prostate cancer cells.
Poku RA; Salako OO; Amissah F; Nkembo AT; Ntantie E; Lamango NS
Am J Cancer Res; 2017; 7(7):1515-1527. PubMed ID: 28744401
[TBL] [Abstract][Full Text] [Related]
8. Polyisoprenylated methylated protein methyl esterase: a putative biomarker and therapeutic target for pancreatic cancer.
Aguilar BJ; Nkembo AT; Duverna R; Poku RA; Amissah F; Ablordeppey SY; Lamango NS
Eur J Med Chem; 2014 Jun; 81():323-33. PubMed ID: 24852279
[TBL] [Abstract][Full Text] [Related]
9. Disruption of actin filaments and suppression of pancreatic cancer cell viability and migration following treatment with polyisoprenylated cysteinyl amides.
Nkembo AT; Salako O; Poku RA; Amissah F; Ntantie E; Flores-Rozas H; Lamango NS
Am J Cancer Res; 2016; 6(11):2532-2546. PubMed ID: 27904769
[TBL] [Abstract][Full Text] [Related]
10. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
[TBL] [Abstract][Full Text] [Related]
11. Suppression of focal adhesion formation may account for the suppression of cell migration, invasion and growth of non-small cell lung cancer cells following treatment with polyisoprenylated cysteinyl amide inhibitors.
Ntantie E; Allen MJ; Fletcher J; Nkembo AT; Lamango NS; Ikpatt OF
Oncotarget; 2018 May; 9(40):25781-25795. PubMed ID: 29899821
[TBL] [Abstract][Full Text] [Related]
12. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
13. Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.
Amissah F; Duverna R; Aguilar BJ; Poku RA; Kiros GE; Lamango NS
Am J Cancer Res; 2014; 4(2):116-34. PubMed ID: 24660102
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J
BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180
[TBL] [Abstract][Full Text] [Related]
15. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
16. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
17. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
18. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
Wu D; Asiedu M; Wei Q
Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
[TBL] [Abstract][Full Text] [Related]
19. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
[TBL] [Abstract][Full Text] [Related]
20. [Verteporfin inhibits proliferation, invasion and migration of MDA-MB-231 human breast cancer cells by down-regulating the expression of Yes-associated protein].
Jiang Y; Liu Y; Zhang Z; Yang J; Ye X; Jin Q; Chen T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1223-1227. PubMed ID: 29089081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]